Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
biotechnology, buy, buyer, characterization, client, concentrated, concentration, correct, criteria, decreasaed, disposal, divest, divesture, downstream, earliest, grow, hardware, Human, INIGHTHAWK, letter, lower, main, opportunity, optimization, organization, penalty, percentage, reclassified, reduction, restructuring, save, scientific, Seller, shed, shorter, software, statutory, stayed, Subtopic, upstream, variation, variety
Removed:
abroad, Agency, Allergy, antibody, authority, BARDA, Biomedical, built, Cantor, closely, combat, commence, commercializing, commercially, Depot, disease, distribution, DoD, ecosystem, efficiently, Emergency, European, exclusivity, exploring, fact, faster, fill, Fitzgerald, headcount, inclusion, innovative, integrated, Kingdom, medical, monoclonal, National, NIAID, obiltoxaximab, opportunistic, orphan, planning, relevant, response, secure, set, SNS, Stockpile, subsidize, therapeutic, Union, unmet, vision
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view